Related Experiment Video
Updated: Aug 5, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel Film
Published on: December 13, 2024
Solubility-Enhanced α‑Mangostin Bilayer Films: Synergizing Mucoadhesion and Protection for Effective Aphthous Ulcer
Waree Tiyaboonchai1, Jiratchaya Lerdsrimongkol1, Prajaree Kuenkoungdee1
1Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
This study created a novel double-layer film for aphthous ulcers using α-mangostin solid dispersions. The film enhances solubility and offers effective localized protection and therapy for oral lesions.
Area of Science:
- Pharmacology
- Materials Science
- Oral Medicine
Background:
- Aphthous ulcers cause significant pain and reduce quality of life.
- α-Mangostin, a mangosteen compound, has anti-inflammatory effects but poor solubility.
- Localized treatments are needed for effective aphthous ulcer management.
Purpose of the Study:
- To develop a double-layer mucoadhesive film for enhanced α-mangostin delivery.
- To improve α-mangostin solubility and provide dual protection and therapy.
- To create a promising formulation for aphthous ulcer treatment.
Main Methods:
- Formulated α-mangostin solid dispersions (MPESD) using PVP K30.
- Fabricated double-layer mucoadhesive films via solvent casting (ethylcellulose and gelatin-HPMC).
- Evaluated film mechanical properties, wettability, residence time, and drug release.
Main Results:
- MPESD significantly increased α-mangostin solubility to 8.12 mg/mL.
- Films exhibited suitable mechanical strength (1.63 N/mm²) and flexibility (20% elongation).
- Optimized films showed >8 h in vitro residence time and 96% drug release within 2 h.
Conclusions:
- The double-layer mucoadhesive film effectively enhances α-mangostin solubility and delivery.
- This formulation offers a promising strategy for localized aphthous ulcer management.
- The developed film provides dual protection and therapeutic benefits for oral lesions.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
